Barclays’s AB InBev BUD Stock Holding History

Barclays’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.59M	Buy	123,786 +117,268	+1,799%	+$8.47M	﹤0.01%	1535
2025 Q4	$417K	Sell	6,518 -161,317	-96%	-$10M	﹤0.01%	3941
2025 Q3	$10M	Buy	167,835 +163,021	+3,386%	+$10.3M	﹤0.01%	1661
2025 Q2	$331K	Sell	4,814 -452,062	-99%	-$30.4M	﹤0.01%	3992
2025 Q1	$28.1M	Buy	456,876 +449,673	+6,243%	+$24.6M	0.01%	871
2024 Q4	$361K	Sell	7,203 -18,253	-72%	-$1.06M	﹤0.01%	4019
2024 Q3	$1.69M	Sell	25,456 -154,315	-86%	-$9.52M	﹤0.01%	2996
2024 Q2	$10.5M	Sell	179,771 -43,720	-20%	-$2.68M	﹤0.01%	1174
2024 Q1	$13.6M	Buy	223,491 +105,267	+89%	+$6.59M	﹤0.01%	1205
2023 Q4	$7.64M	Buy	118,224 +112,890	+2,116%	+$6.67M	﹤0.01%	1736
2023 Q3	$295K	Sell	5,334 -973	-15%	-$55.2K	﹤0.01%	3094
2023 Q2	$358K	Buy	6,307 +4,489	+247%	+$272K	﹤0.01%	2948
2023 Q1	$121K	Sell	1,818 -6,514	-78%	-$394K	﹤0.01%	4074
2022 Q4	$500K	Sell	8,332 -23,361	-74%	-$1.25M	﹤0.01%	3309
2022 Q3	$1.43M	Sell	31,693 -25,327	-44%	-$1.31M	﹤0.01%	1965
2022 Q2	$3.08M	Buy	57,020 +8,911	+19%	+$500K	﹤0.01%	1585
2022 Q1	$2.89M	Buy	48,109 +9,127	+23%	+$563K	﹤0.01%	1592
2021 Q4	$2.36M	Sell	38,982 -20,486	-34%	-$1.19M	﹤0.01%	2277
2021 Q3	$3.35M	Sell	59,468 -8,415	-12%	-$528K	﹤0.01%	1917
2021 Q2	$4.89M	Sell	67,883 -33,955	-33%	-$2.48M	﹤0.01%	1593
2021 Q1	$6.4M	Buy	101,838 +42,187	+71%	+$2.73M	﹤0.01%	1330
2020 Q4	$4.17M	Sell	59,651 -485,915	-89%	-$30.7M	﹤0.01%	1637
2020 Q3	$29.4M	Sell	545,566 -870,951	-61%	-$48.2M	0.02%	578
2020 Q2	$69.8M	Buy	1,416,517 +1,198,858	+551%	+$56M	0.05%	257
2020 Q1	$9.6M	Sell	217,659 -12,281	-5%	-$801K	0.01%	1009
2019 Q4	$18.9M	Buy	229,940 +182,089	+381%	+$15.2M	0.01%	985
2019 Q3	$4.55M	Sell	47,851 -3,111	-6%	-$295K	﹤0.01%	1938
2019 Q2	$4.51M	Sell	50,962 -45,795	-47%	-$3.93M	﹤0.01%	1966
2019 Q1	$8.12M	Sell	96,757 -19,447	-17%	-$1.5M	0.01%	1354
2018 Q4	$7.65M	Buy	116,204 +35,717	+44%	+$2.73M	0.01%	1315
2018 Q3	$7.05M	Sell	80,487 -9,279	-10%	-$904K	﹤0.01%	1498
2018 Q2	$9.04M	Sell	89,766 -11,662	-11%	-$1.16M	0.01%	1291
2018 Q1	$11.2M	Buy	101,428 +29,357	+41%	+$3.26M	0.01%	1130
2017 Q4	$8.04M	Sell	72,071 -33,374	-32%	-$3.93M	0.01%	1309
2017 Q3	$12.6M	Buy	105,445 +25,797	+32%	+$3.02M	0.01%	914
2017 Q2	$8.79M	Sell	79,648 -122,042	-61%	-$14M	0.01%	1060
2017 Q1	$22.1M	Buy	201,690 +75,294	+60%	+$8.09M	0.02%	527
2016 Q4	$13.3M	Buy	126,396 +79,383	+169%	+$8.9M	0.01%	802
2016 Q3	$6.18M	Sell	47,013 -1,252	-3%	-$158K	0.01%	1142
2016 Q2	$6.36M	Sell	48,265 -38,466	-44%	-$4.84M	0.01%	1143
2016 Q1	$10.8M	Sell	86,731 -11,878	-12%	-$1.41M	0.02%	729
2015 Q4	$12.3M	Sell	98,609 -16,404	-14%	-$1.99M	0.02%	790
2015 Q3	$12.2M	Buy	115,013 +55,763	+94%	+$6.47M	0.01%	825
2015 Q2	$7.11M	Buy	59,250 +21,947	+59%	+$2.69M	0.01%	1249
2015 Q1	$4.51M	Sell	37,303 -11,016	-23%	-$1.33M	0.01%	1642
2014 Q4	$5.41M	Sell	48,319 -64,595	-57%	-$7.15M	0.01%	1639
2014 Q3	$12.4M	Buy	112,914 +52,159	+86%	+$5.82M	0.01%	1018
2014 Q2	$6.93M	Buy	60,755 +35,029	+136%	+$3.85M	0.01%	1449
2014 Q1	$2.7M	Buy	25,726 +7,985	+45%	+$810K	﹤0.01%	2252
2013 Q4	$1.88M	Sell	17,741 -10,698	-38%	-$1.09M	﹤0.01%	2738
2013 Q3	$2.82M	Buy	28,439 +15,468	+119%	+$1.47M	﹤0.01%	2209
2013 Q2	$1.17M	Buy	+12,971	New	+$1.24M	﹤0.01%	3163

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Barclays's BUD Position: Q1 2026 in Review

Barclays increased its AB InBev (BUD) stake by 1,799% in Q1 2026, buying an estimated $8.47M and bringing the position to 123,786 shares worth $8.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Barclays first reported a position in BUD in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.8M in Q2 2020. 544 funds tracked by Wall St. Rank hold BUD as of Q1 2026.

Barclays held 123,786 shares of AB InBev worth $8.59M as of Q1 2026.
Barclays bought 117,268 AB InBev shares in Q1 2026, an estimated $8.47M.
AB InBev made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1535 holding.
Barclays first reported a position in AB InBev in Q2 2013 and has held it in 52 quarters since.
Barclays's AB InBev position peaked at $69.8M in Q2 2020.
544 funds tracked by Wall St. Rank held AB InBev as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.